Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137171010> ?p ?o ?g. }
- W2137171010 endingPage "376" @default.
- W2137171010 startingPage "369" @default.
- W2137171010 abstract "Aims Methotrexate is considered by many practitioners to be the agent of choice in the treatment of rheumatoid arthritis. The pharmacokinetics of methotrexate have been reported to exhibit significant intersubject variability. Therefore, this study was undertaken to evaluate the population pharmacokinetics of methotrexate during long-term administration in adults with rheumatoid arthritis. Methods Methotrexate pharmacokinetics were evaluated in a 36 month study of 62 adults with rheumatoid arthritis. Patients received oral or intramuscular doses of methotrexate weekly with pharmacokinetic studies performed every 6 months. Data were analyzed with nonlinear mixed effects modeling. Results Three thousand two hundred and sixty post oral or intramuscular dose serum methotrexate concentrations comprising 425 individual concentration vs time profiles were modeled using NONMEM. Covariates that significantly (P<0.005) influenced the disposition of methotrexate were age (AGE, years), body weight (BW, kg), creatinine clearance (CLCR, l h−1 ), gender (GEN; 0=male, 1=female), dose (DOSE, μmol), and fed vs fasted state (FED; 0=fasted, 1=fed). The final model describing the biexponential disposition of methotrexate was clearance(CL, l h−1 )=(0.0810*BW+0.257*CLCR)*(1–0.167*GEN); central volume (V c, l)=0.311*BW; peripheral volume (V p, l)=0.469*BW-0.169*AGE; intercompartmental clearance (Q, l h−1 )=4.27*(1–0.355*GEN); oral absorption rate constant (kapo, h−1 )=4.70–0.0439*DOSE*(1–0.507*FED); intramuscular absorption rate constant (kaim, h−1 )=0.122*DOSE; relative bioavailability (F )=93.4%; and oral absorption lag time (LAGpo, min)=13.5. Pharmacokinetic parameters (%CV) for a typical fasted male subject in this study were CL, 7.34 l h−1 (27%); V c, 23.5 l (28%); V p, 25.3 l (31%); Q, 4.25 l h−1 (41%); kapo, 3.67 h−1 (77%); and kaim, 3.09 h−1 (44%). Conclusions The population pharmacokinetics of methotrexate in adults with rheumatoid arthritis were well described by this investigation. Substantial interpatient variability was explained by incorporating patient specific data into regression equations predicting pharmacokinetic parameters." @default.
- W2137171010 created "2016-06-24" @default.
- W2137171010 creator A5000942604 @default.
- W2137171010 creator A5005097093 @default.
- W2137171010 creator A5007545564 @default.
- W2137171010 creator A5014147030 @default.
- W2137171010 creator A5027418309 @default.
- W2137171010 date "1998-10-01" @default.
- W2137171010 modified "2023-10-17" @default.
- W2137171010 title "The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis" @default.
- W2137171010 cites W158276252 @default.
- W2137171010 cites W1744000831 @default.
- W2137171010 cites W182370232 @default.
- W2137171010 cites W1975751581 @default.
- W2137171010 cites W1995000196 @default.
- W2137171010 cites W1995527512 @default.
- W2137171010 cites W2001583335 @default.
- W2137171010 cites W2012436282 @default.
- W2137171010 cites W2016284731 @default.
- W2137171010 cites W2018455675 @default.
- W2137171010 cites W2028349643 @default.
- W2137171010 cites W2038086555 @default.
- W2137171010 cites W2039040238 @default.
- W2137171010 cites W2041260334 @default.
- W2137171010 cites W2050088084 @default.
- W2137171010 cites W2076669590 @default.
- W2137171010 cites W2079100622 @default.
- W2137171010 cites W2084142878 @default.
- W2137171010 cites W2112187168 @default.
- W2137171010 cites W2118270386 @default.
- W2137171010 cites W2126213746 @default.
- W2137171010 cites W2131658103 @default.
- W2137171010 cites W2138814539 @default.
- W2137171010 cites W2145434855 @default.
- W2137171010 cites W2152348310 @default.
- W2137171010 cites W2160877509 @default.
- W2137171010 cites W2168681431 @default.
- W2137171010 cites W2236994532 @default.
- W2137171010 cites W2395588997 @default.
- W2137171010 cites W2403163284 @default.
- W2137171010 cites W2414561905 @default.
- W2137171010 cites W2419103830 @default.
- W2137171010 cites W4285719527 @default.
- W2137171010 cites W74072898 @default.
- W2137171010 cites W152090583 @default.
- W2137171010 cites W79779510 @default.
- W2137171010 doi "https://doi.org/10.1046/j.1365-2125.1998.t01-1-00790.x" @default.
- W2137171010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1874158" @default.
- W2137171010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9803986" @default.
- W2137171010 hasPublicationYear "1998" @default.
- W2137171010 type Work @default.
- W2137171010 sameAs 2137171010 @default.
- W2137171010 citedByCount "73" @default.
- W2137171010 countsByYear W21371710102012 @default.
- W2137171010 countsByYear W21371710102013 @default.
- W2137171010 countsByYear W21371710102014 @default.
- W2137171010 countsByYear W21371710102015 @default.
- W2137171010 countsByYear W21371710102016 @default.
- W2137171010 countsByYear W21371710102017 @default.
- W2137171010 countsByYear W21371710102018 @default.
- W2137171010 countsByYear W21371710102019 @default.
- W2137171010 countsByYear W21371710102020 @default.
- W2137171010 countsByYear W21371710102021 @default.
- W2137171010 countsByYear W21371710102022 @default.
- W2137171010 countsByYear W21371710102023 @default.
- W2137171010 crossrefType "journal-article" @default.
- W2137171010 hasAuthorship W2137171010A5000942604 @default.
- W2137171010 hasAuthorship W2137171010A5005097093 @default.
- W2137171010 hasAuthorship W2137171010A5007545564 @default.
- W2137171010 hasAuthorship W2137171010A5014147030 @default.
- W2137171010 hasAuthorship W2137171010A5027418309 @default.
- W2137171010 hasBestOaLocation W21371710102 @default.
- W2137171010 hasConcept C112705442 @default.
- W2137171010 hasConcept C126322002 @default.
- W2137171010 hasConcept C139254425 @default.
- W2137171010 hasConcept C159641895 @default.
- W2137171010 hasConcept C181389837 @default.
- W2137171010 hasConcept C192670549 @default.
- W2137171010 hasConcept C2776239304 @default.
- W2137171010 hasConcept C2777056448 @default.
- W2137171010 hasConcept C2777077863 @default.
- W2137171010 hasConcept C2777575956 @default.
- W2137171010 hasConcept C2781059491 @default.
- W2137171010 hasConcept C2908647359 @default.
- W2137171010 hasConcept C71924100 @default.
- W2137171010 hasConcept C90924648 @default.
- W2137171010 hasConcept C98274493 @default.
- W2137171010 hasConcept C99454951 @default.
- W2137171010 hasConceptScore W2137171010C112705442 @default.
- W2137171010 hasConceptScore W2137171010C126322002 @default.
- W2137171010 hasConceptScore W2137171010C139254425 @default.
- W2137171010 hasConceptScore W2137171010C159641895 @default.
- W2137171010 hasConceptScore W2137171010C181389837 @default.
- W2137171010 hasConceptScore W2137171010C192670549 @default.
- W2137171010 hasConceptScore W2137171010C2776239304 @default.
- W2137171010 hasConceptScore W2137171010C2777056448 @default.
- W2137171010 hasConceptScore W2137171010C2777077863 @default.
- W2137171010 hasConceptScore W2137171010C2777575956 @default.